Company: HRTX
Filing Date: 2025-09-09
Form Type: PRE 14A
Source: 0000950170-25-113827
Chunk: 1

Company: HERON THERAPEUTICS, INC. /DE/
Filing Date: 2025-09-09
Form: PRE 14A
Chunk 1
---
 and outstanding prior to such issuance; and |

| 2. | To approve, pursuant to Nasdaq Listing Rule 5635(d), the issuance of a number of shares of the Company’s Common Stock in connection with the conversion of the Company’s Series A Convertible Preferred Stock, par value $0.01 per share (“Series A Convertible Preferred Stock”) held by several non-affiliated holders, which could, under certain circumstances that may occur in the future, exceed 19.99% of the number of shares of the Company’s Common Stock issued and outstanding prior to such issuance. |

Stockholders will be able to attend the Special Meeting and vote electronically and submit questions during the Special Meeting, all by visiting [●] . To participate in the Special Meeting, stockholders of record will need the 16-digit control number included on their proxy card. If your shares are held in street name and your voting instruction form indicates that you may vote those shares through the http://www.proxyvote.com website, then you may access, participate in, and vote electronically during the Special Meeting with the 16-digit access code indicated on that voting instruction form. Otherwise, stockholders who hold their shares in street name should contact their broker, bank, or other agent (preferably at least five days before the Special Meeting) and obtain a “legal proxy” in order to be able to attend, participate in, or vote at the Special Meeting. The Special Meeting will begin promptly at [●] [a.m.][p.m.] Eastern Time. We encourage you to access the Special Meeting webcast prior to the start time. Online check-in will begin at [●] [a.m.][p.m.] Eastern Time, and you should allow ample time for the check-in procedures. Only stockholders of record at the close of business on [●], 2025 (the “ Record Date ”) will be entitled to notice of, and to vote at, the Special Meeting.

| BY ORDER OF THE BOARD OF DIRECTORS |
| /s/ Ira Duarte                     |
| Cary, North Carolina               |
| [●], 2025                          |

<div align='center'>2

IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE SPECIAL MEETING OF STOCKHOLDERS TO BE HELD ON [●], 2025:

YOUR VOTE IS IMPORTANT</div>

You are cordially invited to attend the Special Meeting. Instructions on how to participate in the Special Meeting and demonstrate proof of stock ownership are